Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. by Molly B. El Alam (10231830)

Data_Sheet_1_Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.docx by Chantal C. Clark (10684632)

“…</p><p>Conclusion: We observed an association between the use of preexisting thromboprophylaxis and a decreased risk of TE during COVID-19. This suggests that these therapies are beneficial for coping with COVID-19 associated hypercoagulability. …”

Decreased hospital admissions for cardiovascular emergencies during COVID-19 associated RM. by Heiko Bugger (105080)

Decrease of HLA-DR expression is more pronounced in severe cases. by Sanja Matic (9931091)

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Persistent AF decreases left atrial organizational index. by Terrence Pong (511730)

Subjects:

Decreased growth of <i>S</i>. <i>aureus</i> CBS2016-05 and PS/BAC/317/16/W during PC storage in comparison to trypticase soy broth (TSB). by Basit Yousuf (630368)

Subjects:

Lines carrying three mCHG-decreasing alleles with mCHH-decreasing <i>NRPE1’</i> allele. by Eriko Sasaki (501178)

Decrease in circulating iNKT cell activation during regadenoson (RA) infusion into patients with COVID-19. by Joseph Rabin (7399436)

Subjects:

Decreased test sensitivity: Screening the whole population. by Timo de Wolff (9904467)

ERK inhibition decreases CDK1 and Smo expression. by Xiaojuan Li (351842)

Voluntary mobility and distancing measures decrease the spread of SARS-CoV2 in Mexico City by Guillermo de Anda‐Jáuregui (9183620)

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing for the iliocostalis muscle. by Christoph Anders (4068499)

Subjects:

DDX3 levels are not decreased in MCMV-infected cells. by Olha Puhach (9500132)

Stacked bar plots of predicted absolute IPD cases per year from 2006 to 2031 in Germany for three different age groups (<2y, 16-59y, ≥60y). by Matthias Horn (78815)

Subjects:

Hypothesis that explains and predicts expansion of ages of KD due to decreased IgG levels. by Hiromi Yamaguchi (2396248)

Subjects:

Prevalence of smoking during COVID19 (n = 1844). by Mahmoud A. Alomari (14780446)

Subjects:

Confinement information due to COVID19 (n = 1844). by Mahmoud A. Alomari (14780446)

Subjects:

Patients with high baseline gut richness and diversity have significantly greater decreases in diversity over time. by Molly B. El Alam (10231830)

COVID-19 incidence increases over time with a decreased importance of genetic COVID-19 susceptibility. by C. A. Robert Warmerdam (12568808)

“…The shaded area represents the 95% confidence interval for the model fit. c) The contribution of COVID-19 susceptibility to the risk of having had COVID-19 slowly decreased over time. d) Regression coefficients of the COVID-19 susceptibility PGS and ever testing positive for SARS-CoV-2 by PCR test over time. …”